Society of Diabetic Nephropathy Prevention Journal of Preventive Epidemiology 2476-3934 10 1 2025 01 01 Role of lipoprotein (a) in kidney diseases; a review of recent data e38256 e38256 10.34172/jpe.2025.38256 EN Sara Ghaseminejad Kermani https://orcid.org/0000-0002-1730-8437 Jalal Rezaei https://orcid.org/0009-0000-9601-9803 Sara Rasta https://orcid.org/0009-0002-5081-7935 Meysam Arbuzia https://orcid.org/0000-0002-4643-7748 Tayabeh Bahmani https://orcid.org/0000-0001-5954-1715 Hossein Mardanparvar https://orcid.org/0000-0001-7455-5373 Journal Article 10.34172/jpe.2025.38256 2024 08 17 2024 09 30 Lipoprotein (a) is a type of lipoprotein that consists of a cholesterol-rich low-density lipoprotein particle bound to a unique protein called apolipoprotein (a). A strengthened risk of vascular diseases, such as stroke and coronary artery disease is accompanied by elevated levels of this protein. However, recent research has also highlighted the potential role of lipoprotein (a) in kidney-related conditions. Lp (a) appears to play a significant role in kidney diseases. An increased risk of kidney disease development and progression, diabetic nephropathy and renal artery stenosis, and renal transplant dysfunction accompanies high plasma values of Lp (a).